de Lucca SL, Narciso-Schiavon JL

Idioma: Español
Referencias bibliográficas: 8
Paginas: 469-470
Archivo PDF: 105.92 Kb.

FRAGMENTO

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Stine JG, Wynter JA, Niccum B, Kelly V, Caldwell SH, Shah NL. Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C. Ann Hepatol 2017; 16: 215-20.

2. Homa K, Majkowska L. Difficulties in interpreting HbA(1c) results. Pol Arch Med Wewn 2010; 120: 148-54.

3. Hoberman HD, Chiodo SM. Elevation of the hemoglobin A1 fraction in alcoholism. Alcohol Clin Exp Res 1982; 6: 260-6.

4. Elkrief L, Rautou PE, Sarin S, Valla D, Paradis V, Moreau R. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver Int 2016; 36: 936-48.

5. Cacciatore L, Cozzolino G, Giardina MG, De Marco F, Sacca L, Esposito P, Francica G, et al. Abnormalities of glucose metabolism induced by liver cirrhosis and glycosylated hemoglobin levels in chronic liver disease. Diabetes Res 1988; 7: 185-8.

6. Nomura Y, Nanjo K, Miyano M, Kikuoka H, Kuriyama S, Maeda M, Miyamura K. Hemoglobin A1 in cirrhosis of the liver. Diabetes Res 1989; 11: 177-80.

7. Nadelson J, Satapathy SK, Nair S. Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis. Int J Endocrinol 2016; 2016: 8390210.

8. Gonzalez-Casas R, Jones EA, Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World J Gastroenterol 2009; 15: 4653-8.